ENCOD
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
  • Donate
  • Covid-19 messages
  • News
  • Organisation
    • About us
    • Our Team
      • WORKING GROUPS
      • STUDIES
      • GENERAL ASSEMBLIES
      • FINANCES
    • Our Mission
    • FAQ
    • IN THE PRESS
    • ANNUAL REPORTS
    • ENCOD MEMBERS
    • INFO FOR MEMBERS
  • Join us
  • Actions & Events
    • CAMPAIGNS
      • FREEDOM TO FARM
        • FREEDOM TO FARM
        • FREEDOM TO FARM IS THE FIRST TEST OF RELIGIOUS FREEDOM
        • FREEDOM TO FARM AND CANNABIS SOCIAL CLUBS FOR PEOPLE WHO USE CANNABIS AS A MEDICINE
        • FREEDOM TO FARM POSTERS
        • FREEDOM TO FARM STICKERS
      • Cannabis Social Clubs
        • HOW TO CREATE A CANNABIS SOCIAL CLUB
        • EXAMPLES OF CSC’S IN EUROPE
        • Cannabis Social Clubs in Aktion
        • PROPOSAL TO REGULATE THE SELF CULTIVATION AND CANNABIS SOCIAL CLUBS IN BELGIUM
        • Catalonia regulates the Cannabis Social Clubs
        • WORKSHOP ‘HOW TO SET UP A CSC IN GERMANY’
      • 2017
      • 2014
      • 2010 – 2013
      • 2009
      • 2008
      • 2007
      • 2006
      • 1995 – 2005
      • EU LOBBY CAMPAIGN
        • 2011
        • 2010
        • 2009
        • 2008
        • 2007
        • 2006
        • 2005
        • 2004
    • ACTION APPEALS
  • Bulletins
  • Video Archive
October 11, 2021  |  By Maja In 2021, FREEDOM TO FARM, WHO ECDD

Pre-review of kratom at the WHO ECDD

banner_F2F_klein

Dr. Fabian Steinmetz gave a statement on kratom at the Forty-fourth Expert Committee on Drug Dependence.

 

Dear Expert Committee on Drug Dependence,
we would like to encourage the ECDD not to classify kratom (Mitragyna speciosa) as a controlled substance. First of all, banning plants has never solved any drug–related issues. Products derived from hemp (Cannabis sativa), poppy (Papaver somniferum), and coca (Coca erythroxylum), and chemical substitutes are readily available worldwide. However, banning those plants inflicted direct and indirect harm to millions of people, particularly ethnic minorities. There is a scientific consensus that sensible regulations dependent on use prevalence and substance–specific risks are the best approach to reduce harm to health and society. A ban on kratom would particularly affect people with traditional and medical use. For many people, kratom is a safe pain medication or mild opioid substitute.

As a toxicologist and professional risk assessor, I would like to emphasise that many plant extracts in high concentrations have psychotropic effects but could also, at high and constant exposure, provoke organ toxicity, e.g. lavender (Lavandula angustifolia), mugwort (Artemisia vulgaris), tea (Camellia sinensis), chamomile (Matricaria recutita), lettuce (Lactuca spp) etc. Hence, this cannot be the rationale for banning a plant, particularly not if there is an overall long history of safe use.

While extracts/isolates should undergo regulatory approaches comparable to other plant–based pharmaceuticals (i.e. dependent on potency), it is important not to schedule the plant and traditional formulations to avoid obstruction of medical research, obstruction of current medical therapies as opioid substitute, analgesic etc. (particularly when access to healthcare is limited) and to avoid the general criminalisation of people using kratom. Particularly the latter is harmful on its own but also may lead to unhealthier substance choices. Hence, the cultivation, trade and use of kratom should not be prosecuted. This should also encompass novel formulations if typical alkaloid exposure is not exceeded.

Overall, the use prevalence is, compared to alcoholic beverages and hemp–based products, not particularly high although the plant and its effects are known in the Western world for over 100 years. One reason might be the taste which is not perceived well by many people using kratom. Another reason might be unpleasant effects, e.g. dizziness, drowsiness, particularly at high doses. Due to the fact that the main alkaloid (mitragynine) is a prod–drug towards the μ–opioid receptor, it is unlikely that other routes of administration than the oral route could lead to use patterns associated with severe substance use disorders (cf. first-pass effect). The active metabolite (7–hydroxymitragynine) is also present in the plant but only in pharmacologically irrelevant trace levels. This clearly differentiates kratom’s main alkaloid mitragynine from cocaine or morphine.

The political challenges with regard to climate change and mass extinction should also remind us not to interfere with ecosystems light–heartedly. The kratom plant, growing as a tropical evergreen tree, is an important part of local ecosystems and these ecosystems should not be deliberately harmed. Despite that, we already know that banning plants has never been a successful strategy. When looking at other banned plants, it is not unlikely that banning the plant would even encourage more cultivation, extractions and eventually chemical alterations (cf. poppy to heroin or coca to cocaine hydrochloride/freebase).
Although, as described above, this is less likely with kratom, the creation of more harmful derivatives should be a reminder of negative consequences based on drug prohibition. Currently, kratom is considered a rather unproblematic remedy used by a rather small population, nevertheless, “technological progress” due to prohibition should not be underestimated. It is important not to give organised crime groups further opportunities to increase their market share.
Overall, considering health and social implications, the cultivation, trade, and use of kratom should not be prosecuted. Therefore, it is important to respect communities and their freedom to farm, use, and trade recreational and medical goods of low concern.

Kind regards,

Dr. Fabian Pitter Steinmetz

Member / Scientific Advisor of ENCOD

Click here to read the statement.

Click here for more information about the event.

 

Previous StoryEducation is not a crime!
Next StoryMalta and Cannabis: Changes on the horizon

Related Articles

  • Screenshot at 2022-06-19 11-08-17
    Farmability and pharmability
  • Screenshot at 2021-12-11 13-24-17
    Annual and country reports 2021

Categories

Archives

  • About us
  • Downloads
  • Contact
  • Privacy Policy
  • Legal Notice & Terms of Use
  • Imprint

Copyright ©2018 ThemeFuse. All Rights Reserved

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
Cookie SettingsAccept All
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
CookieDurationDescription
cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytics
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
Others
Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
SAVE & ACCEPT

REPUBLISHING TERMS

You may republish this article online or in print under our Creative Commons license. You may not edit or shorten the text, you must attribute the article to ENCOD and you must include the author’s name in your republication.

If you have any questions, please email thujer@gmail.com

License

Creative Commons License AttributionCreative Commons Attribution
Pre-review of kratom at the WHO ECDD